2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD
Publication Title
AHA, Know Diabetes by Heart
Document Type
Presentation
Publication Date
10-28-2020
Abstract
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Clinical Institute
Cardiovascular (Heart)
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Cardiology
Specialty/Research Institute
Endocrinology
